Changes in plasma LDL and HDL composition in patients undergoing cardiac surgery

Lipids

Volumn 42, Issue 12, 2007, Pages 1143-1153

  Hacquebard, M ^a   Ducart, A ^a   Schmartz, D ^a   Malaisse, W J ^a   Carpentier, Y A ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Acute phase response; Alpha tocopherol; Cardiac surgery; Cardiopulmonary bypass; HDL; LDL; Lipids; Oxidative stress; Particle size

Indexed keywords

OXIDATIVE STRESS; PARTICLE SIZE; PHASE COMPOSITION; PLASMA DIAGNOSTICS; PROTEINS; RESPIRATORY THERAPY; SURGERY;

ACUTE PHASE RESPONSE; ALPHA-TOCOPHEROL; CARDIAC SURGERY; CARDIOPULMONARY BYPASS; SEPSIS;

CARDIOLOGY;

ALPHA TOCOPHEROL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HEART SURGERY; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; PARTICLE SIZE; PHOSPHOLIPID BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-TOCOPHEROL; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CARDIOPULMONARY BYPASS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROGEN PEROXIDE; MALE; MIDDLE AGED; PHOSPHOLIPIDS; TRIGLYCERIDES;

EID: 37349054370     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-007-3114-9     Document Type: Article

References (57)

1. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-54
2. Carpentier YA, Scruel O (2002) Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 5:153-8
3. Feingold KR, Staprans I, Memon RA, Moser AH, Shigenaga JK, Doerrler W, Dinarello CA, Grunfeld C (1992) Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 33:1765-76
4. Fraunberger P, Schaefer S, Werdan K, Walli AK, Seidel D (1999) Reduction of circulating cholesterol and apolipoprotein levels during sepsis. Clin Chem Lab Med 37:357-62
5. Akgun S, Ertel NH, Mosenthal A, Oser W (1998) Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute-phase response. J Lab Clin Med 131:103-8
6. Chien JY, Jerng JS, Yu CJ, Yang PC (2005) Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 33:1688-93
7. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ, Barie PS, Rubin AL, (2001) Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med 29:1563-8
8. Hudgins LC, Parker TS, Levine DM, Gordon BR, Saal SD, Jiang XC, Seidman CE, Tremaroli JD, Lai J, Rubin AL (2003) A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res 44:1489-98
9. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45:1169-96
10. Kitchens RL, Thompson PA, Munford RS, O'Keefe GE (2003) Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res 44:2339-48
11. Hardardottir I., Grunfeld C, Feingold KR (1994) Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol 5:207-15
12. Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M (1995) Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96:2758-67
13. Stephens CJ, Graham RM, Yadava OP, Leong LL, Sturm MJ, Taylor RR (1992) Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery. Cardiovasc Res 26:25-31
14. Cunningham MJ, Boucher TM, McCabe CH, Horowtiz GL, Pasternak RC (1987) Changes in total cholesterol and high-density lipoprotein cholesterol in men after coronary artery bypass grafting. Am J Cardiol 60:1393-4
15. Levy JH, Tanaka KA (2003) Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75:S715-20
16. Larmann J, Theilmeier G (2004) Inflammatory response to cardiac surgery; cardiopulmonary bypass versus non-cardiopulmonary bypass surgery. Best Pract Res Clin Anaesthesiol 18:425-38
17. Goudeau JJ, Clermont G, Guillery O, Lemaire-Ewing S, Musat A, Vernet M, Vergely C, Guiguet M, Rochette L, Girard C (2007) In high-risk patients, combination of antiinflammatory procedures during cardiopulmonary bypass can reduce incidences of inflammation and oxidative stress. J Cardiovasc Pharmacol 49:39-45
18. Coghlan JG, Flitter WD, Clutton SM, Ilsley CD, Rees A, Slater TF (1993) Lipid peroxidation and changes in vitamin E levels during coronary artery bypass grafting. J Thorac Cardiovasc Surg 106:268-74
19. Pouliot M, Fiset ME, Masse M, Naccache PH, Borgeat P (2002) Adenosine up-regulates cyclooxygenase-2 in human granulocytes: impact on the balance of eicosanoid generation. J Immunol 169:5279-86
20. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W (2001) Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 104:1108-13
21. Nzuzi Tembo N, Bazelmans C, Dufourny G, Levèque A, Nève J, Carpentier YA (2006) Comparison of cardiovascular risk factors between different ethnic groups living in the region of Brussels. 28th ESPEN Congress, Istanbul (Turkey) Abstract
22. Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-53
23. Jiang ZY, Hunt JV, Wolff SP (1992) Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 202:384-9
24. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G (1991) Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 53:314S-321S
25. Traber MG, Kayden HJ (1989) Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins. Am J Clin Nutr 49:517-26
26. Wong WM, Stephens JW, Acharya J, Hurel SJ, Humphries SE, Talmud PJ (2004) The APOA4 T347S variant is associated with reduced plasma TAOS in subjects with diabetes mellitus and cardiovascular disease. J Lipid Res 45:1565-71
27. Eckerson HW, Wyte CM, La Du BN (1983) The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 35:1126-38
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-75
29. Dubois DY, Cantraine F, Malmendier CL (1987) Comparison of different sandwich enzyme immunoassays for the quantitation of human apolipoproteins A-I and A-II. J Immunol Methods 96:115-20
30. Cotton F, Thiry P, Hsain AB, Boeynaems JM (2001) Analyzer transfer of a broad range high-sensitivity C-reactive protein immunoassay. Clin Lab 47:405-9
31. Pruzanski W, Stefanski E, de Beer FC, de Beer MC, Ravandi A, Kuksis A (2000) Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. J Lipid Res 41:1035-47
32. Gotto AM Jr, Pownall HJ, Havel RJ (1986) Introduction to the plasma lipoproteins. Methods Enzymol 128:3-41
33. Eisenberg S (1984) High density lipoprotein metabolism. J Lipid Res 25:1017-58
34. Malmendier CL, Amerijckx JP, Bihain BE, Fischer ML (1985) Changes in apolipoprotein and lipids in patients after surgery. Biomed Pharmacother 39:192-5
35. Cavarocchi NC, England MD, O'Brien JF, Solis E, Russo P, Schaff HV, Orszulak TA, Pluth JR, Kaye MP (1986) Superoxide generation during cardiopulmonary bypass: is there a role for vitamin E? J Surg Res 40:519-27
36. McColl AJ, Keeble T, Hadjinikolaou L, Cohen A, Aitkenhead H, Glenville B, Richmond W (1998) Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem 35(Pt 5):616-23
37. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR (1995) Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 23:646-51
38. Wu A, Hinds CJ, Thiemermann C (2004) High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 21:210-21
39. Chuang CC, Shiesh SC, Chi CH, Tu YF, Hor LI, Shieh CC, Chen MF (2006) Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care 10:R36
40. Ballmer PE, Reinhart WH, Jordan P, Buhler E, Moser UK, Gey KF (1994) Depletion of plasma vitamin C but not of vitamin E in response to cardiac operations. J Thorac Cardiovasc Surg 108:311-20
41. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR (1988) Changes in serum lipoprotein pattern induced by acute infections. Metabolism 37:859-65
42. van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA, Verhoef J, van Kessel KP (2003) Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 31:1359-66
43. Rosenson RS (1993) Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 22:933-40
44. Pfohl M, Schreiber I, Liebich HM, Haring HU, Hoffmeister HM (1999) Upregulation of cholesterol synthesis after acute myocardial infarction - is cholesterol a positive acute phase reactant? Atherosclerosis 142:389-93
45. Feingold KR, Krauss RM, Pang M, Doerrler W, Jensen P, Grunfeld C (1993) The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab 76:1423-7
46. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR (1992) Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 74:1045-52
47. Memon RA, Staprans I, Noor M, Holleran WM, Uchida Y, Moser AH, Feingold KR, Grunfeld C (2000) Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol 20:1536-42
48. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, de Beer FC (1986) Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem 261:9644-51
49. Clifton PM, Mackinnon AM, Barter PJ (1985) Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. J Lipid Res 26:1389-98
50. Hosoai H, Webb NR, Glick JM, Tietge UJ, Purdom MS, de Beer FC, Rader DJ (1999) Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice. J Lipid Res 40:648-53
51. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ, Barie PS, Rubin AL (1996) Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med 24:584-9
52. Eisenberg S, Gavish D, Oschry Y, Fainaru M, Deckelbaum RJ (1984) Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. J Clin Invest 74:470-82
53. Deckelbaum RJ, Granot E, Oschry Y, Rose L, Eisenberg S (1984) Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 4:225-31
54. Ly H, Francone OL, Fielding CJ, Shigenaga JK, Moser AH, Grunfeld C, Feingold KR (1995) Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J Lipid Res 36:1254-63
55. Khovidhunkit W, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C (2001) Cholesterol efflux by acute-phase high density lipoprotein: role of lecithin: cholesterol acyltransferase. J Lipid Res 42:967-75
56. Christen S, Finckh B, Lykkesfeldt J, Gessler P, Frese-Schaper M, Nielsen P, Schmid ER, Schmitt B (2005) Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation. Free Radic Biol Med 38:1323-32
57. Hacquebard M, Ducart A, Schmartz D, Tembo N, Carpentier YA (2004) Tocopherol in lipoproteins and blood cells after cardiac surgery. Ann N Y Acad Sci 1031:432-4